Evaluation of the neuropathic component of pain in patients with fibromyalgia with painDETECT and DN4

dc.contributor.authorDemirdal, Ümit Seçil Irdal
dc.contributor.authorKuculmez, Ozlem
dc.contributor.authorAşkın, Ayhan
dc.contributor.authorTosun, Aliye Kapukiran
dc.contributor.authorKoçak, Duygu
dc.date.accessioned2026-01-24T12:20:47Z
dc.date.available2026-01-24T12:20:47Z
dc.date.issued2024
dc.departmentAlanya Alaaddin Keykubat Üniversitesi
dc.description.abstractFibromyalgia (FMS) is generally associated with neuropathic pain (NP) because of the neuropathic symptoms frequently observed in patients with FMS. The aim of the study is to evaluate the neuropathic component of FMS with the painDETECT (PD-Q) and Douler Neuropathic 4 (DN4) scales. Female patients diagnosed as FMS according to the American College of Rheumatology’s 2010 FMS criteria and female healthy volunteers are included in the study. After demographic evaluation, the patients and volunteers were asked to fill out Visual Analog Score (VAS), PD-Q, and DN4 scale forms. The Fibromyalgia Impairment Questionnaire (FIQ) evaluated life quality and function. There were 66 patients in the FMS group with a mean age of 46.16± 10.66 and 61 patients in the control group with a mean age of 44.93± 12.72. It was determined that there was a significant difference between the VAS, PD-Q, and DN4 values of FMS and control groups (tVAS = 5,025 p < 0.05, t PD-Q = 5,025 p < 0.05, tDN4 = 7,885 p < 0.05). The mean pain score (VAS) and NP level (DN4 and PD-Q) of FMS patients were significantly higher than healthy individuals. In addition, it was determined that VAS (p = 0.001) and PD-Q (p = 0.046) values were found to be significant predictors of the FIQ values. FMS patients may have pain with a neuropathic component, and it seems useful to evaluate neuropathic characteristics with PD-Q and DN4. If the components of pain are researched carefully, more improvement may be achieved in pain and functional capacity. © 2024 Ondokuz Mayis Universitesi. All rights reserved.
dc.identifier.doi10.52142/omujecm.41.2.4
dc.identifier.endpage252
dc.identifier.issn1309-4483
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85198483033
dc.identifier.scopusqualityQ3
dc.identifier.startpage246
dc.identifier.urihttps://doi.org/10.52142/omujecm.41.2.4
dc.identifier.urihttps://hdl.handle.net/20.500.12868/4579
dc.identifier.volume41
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherOndokuz Mayis Universitesi
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20260121
dc.subjectchronic fatigue
dc.subjectfibromyalgia
dc.subjectfibromyalgia syndrome
dc.subjectneuropathic pain
dc.titleEvaluation of the neuropathic component of pain in patients with fibromyalgia with painDETECT and DN4
dc.typeArticle

Dosyalar